Stocktoria
Aimei Health Technology Co., Ltd. AFJK
Aimei Health Technology Co., Ltd. (AFJK) earns a Piotroski F-score of 3/9 (weak financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
How it ranks in Finance, Insurance & Real Estate · percentile among 1129 companies
Percentile vs other Finance, Insurance & Real Estate companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 3/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | -0.278 |
| Retained earnings / assets | -0.335 |
| EBIT / assets | -0.069 |
| Equity / liabilities | -0.999 |
Sector peers · similar-size Finance, Insurance & Real Estate companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| AFJK | Aimei Health Technology Co., Ltd. | 3/9 | -4.43 | 80.1 | — |
| IPCX | Inflection Point Acquisition Corp. III | 3/9 | -1.27 | 713.8 | — |
| INV | Innventure, Inc. | 4/9 | -2.76 | — | — |
| INNI | Innovaro, Inc. | 1/9 | — | — | -96.4% |
| JFTH | Japan Food Tech Holdings, Inc. | 2/9 | — | — | — |
| MUFG | MITSUBISHI UFJ FINANCIAL GROUP INC | 4/9 | — | — | +9.5% |
| MFG | MIZUHO FINANCIAL GROUP INC | 4/9 | — | — | +7.6% |
All Finance, Insurance & Real Estate companies →
About Aimei Health Technology Co., Ltd.
Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to acquire small cap businesses in the biopharmaceutical, medical technology and device industries, as well as in the diagnostic and other service sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.
FAQ
Is AFJK financially healthy?
Aimei Health Technology Co., Ltd.'s Piotroski F-score is 3/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does AFJK pay a dividend?
No, Aimei Health Technology Co., Ltd. does not currently pay a dividend.
What is AFJK's P/E ratio?
Aimei Health Technology Co., Ltd.'s trailing price-to-earnings (P/E) ratio is about 80.1×, based on its latest annual earnings.
Is AFJK a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Aimei Health Technology Co., Ltd.: a Piotroski F-score of 3/9, an Altman Z″ in the distress zone, a P/E of about 80.1×. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.